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Abstract: Helminth infections are ubiquitous in grazing ruminant production systems, and are responsible
for significant costs and production losses. Anthelmintic Resistance (AR) in parasites is now widespread
throughout Europe, although there are still gaps in our knowledge in some regions and countries. AR
is a major threat to the sustainability of modern ruminant livestock production, resulting in reduced
productivity, compromised animal health and welfare, and increased greenhouse gas emissions through
increased parasitism and farm inputs. A better understanding of the extent of AR in Europe is needed to
develop and advocate more sustainable parasite control approaches. A database of European published
and unpublished AR research on gastrointestinal nematodes (GIN) and liver fluke (Fasciola hepatica) was
collated by members of the European COST Action ”COMBAR” (Combatting Anthelmintic Resistance
in Ruminants), and combined with data from a previous systematic review of AR in GIN. A total of
197 publications on AR in GIN were available for analysis, representing 535 studies in 22 countries
and spanning the period 1980-2020. Reports of AR were present throughout the European continent
and some reports indicated high within-country prevalence. Heuristic sample size-weighted estimates of
European AR prevalence over the whole study period, stratified by anthelmintic class, varied between
0 and 48%. Estimated regional (country) prevalence was highly heterogeneous, ranging between 0%
and 100% depending on livestock sector and anthelmintic class, and generally increased with increasing
research effort in a country. In the few countries with adequate longitudinal data, there was a tendency
towards increasing AR over time for all anthelmintic classes in GIN: aggregated results in sheep and
goats since 2010 reveal an average prevalence of resistance to benzimidazoles (BZ) of 86%, macrocyclic
lactones except moxidectin (ML) 52%, levamisole (LEV) 48%, and moxidectin (MOX) 21%. All major
GIN genera survived treatment in various studies. In cattle, prevalence of AR varied between anthelmintic
classes from 0-100% (BZ and ML), 0-17% (LEV) and 0-73% (MOX), and both Cooperia and Ostertagia
survived treatment. Suspected AR in F. hepatica was reported in 21 studies spanning 6 countries. For
GIN and particularly F. hepatica, there was a bias towards preferential sampling of individual farms
with suspected AR, and research effort was biased towards Western Europe and particularly the United
Kingdom. Ongoing capture of future results in the live database, efforts to avoid bias in farm recruitment,
more accurate tests for AR, and stronger appreciation of the importance of AR among the agricultural
industry and policy makers, will support more sophisticated analyses of factors contributing to AR and
effective strategies to slow its spread.
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Abstract – Helminth infections are ubiquitous in grazing ruminant production systems, and are responsible for
significant costs and production losses. Anthelmintic Resistance (AR) in parasites is now widespread throughout
Europe, although there are still gaps in our knowledge in some regions and countries. AR is a major threat to the sus-
tainability of modern ruminant livestock production, resulting in reduced productivity, compromised animal health and
welfare, and increased greenhouse gas emissions through increased parasitism and farm inputs. A better understanding
of the extent of AR in Europe is needed to develop and advocate more sustainable parasite control approaches.
A database of European published and unpublished AR research on gastrointestinal nematodes (GIN) and liver fluke
(Fasciola hepatica) was collated by members of the European COST Action “COMBAR” (Combatting Anthelmintic
Resistance in Ruminants), and combined with data from a previous systematic review of AR in GIN. A total of 197
publications on AR in GIN were available for analysis, representing 535 studies in 22 countries and spanning the
period 1980–2020. Reports of AR were present throughout the European continent and some reports indicated high
within-country prevalence. Heuristic sample size-weighted estimates of European AR prevalence over the whole study
period, stratified by anthelmintic class, varied between 0 and 48%. Estimated regional (country) prevalence was highly
heterogeneous, ranging between 0% and 100% depending on livestock sector and anthelmintic class, and generally
increased with increasing research effort in a country. In the few countries with adequate longitudinal data, there
was a tendency towards increasing AR over time for all anthelmintic classes in GIN: aggregated results in sheep
and goats since 2010 reveal an average prevalence of resistance to benzimidazoles (BZ) of 86%, macrocyclic lactones
except moxidectin (ML) 52%, levamisole (LEV) 48%, and moxidectin (MOX) 21%. All major GIN genera survived
treatment in various studies. In cattle, prevalence of AR varied between anthelmintic classes from 0–100% (BZ and
ML), 0–17% (LEV) and 0–73% (MOX), and both Cooperia and Ostertagia survived treatment. Suspected AR in
F. hepatica was reported in 21 studies spanning 6 countries. For GIN and particularly F. hepatica, there was a bias
towards preferential sampling of individual farms with suspected AR, and research effort was biased towards Western
Europe and particularly the United Kingdom. Ongoing capture of future results in the live database, efforts to avoid
bias in farm recruitment, more accurate tests for AR, and stronger appreciation of the importance of AR among the
agricultural industry and policy makers, will support more sophisticated analyses of factors contributing to AR and
effective strategies to slow its spread.
Key words: Anthelmintic resistance, Ruminants, Europe, Gastrointestinal nematodes, Liver fluke, Prevalence, Maps,
Database.
Résumé – Importance croissante de la résistance aux anthelminthiques chez les ruminants européens : création
et méta-analyse d’une base de données ouverte. Les helminthes sont omniprésents dans les systèmes de production
de ruminants au pâturage et sont responsables de coûts et de pertes de production importants. La résistance aux
anthelminthiques (RA) des parasites est maintenant répandue dans toute l’Europe, bien qu’il existe encore des
lacunes dans nos connaissances dans certaines régions et certains pays. La RA est une menace majeure pour la
pérennité de la production moderne de ruminants, en diminuant la productivité, en compromettant la santé et le
bien-être des animaux, et en augmentant les émissions de gaz à effet de serre au travers d’une augmentation du
parasitisme et des intrants agricoles. Une meilleure compréhension de l’étendue de la RA en Europe est nécessaire
pour développer et préconiser des approches de lutte antiparasitaire plus durables. Une base de données intégrant
des informations publiées et non publiées en Europe concernant la RA des nématodes gastro-intestinaux (NGI) et
de la douve du foie (Fasciola hepatica) a été compilée par les membres de l’action européenne
COST « COMBAR » (« Combattre la résistance aux anthelminthiques chez les ruminants ») et combinée avec les
données d’une précédente étude systématique concernant la RA des NGI. Au total, 197 publications sur la RA des
NGI étaient disponibles pour analyse, représentant 535 études dans 22 pays et couvrant la période 1980–2020. Des
signalements de RA étaient présents sur tout le continent européen et certains rapports indiquaient une forte
prévalence nationale. Les estimations heuristiques pondérées par la taille de l’échantillon de la prévalence de la RA
en Europe sur toute la période d’étude, stratifiées par classe d’anthelminthiques, variaient de 0 à 48 %. La
prévalence régionale (nationale) estimée était très hétérogène, variant entre 0 % et 100 % selon le secteur de
l’élevage et la classe d’anthelminthique, et augmentait généralement avec les efforts de recherche dans le pays.
Dans les quelques pays disposant de données longitudinales adéquates, il y avait une tendance à l’augmentation de
la RA au fil du temps pour toutes les classes d’anthelminthiques des NGI : les résultats agrégés chez les ovins et
caprins depuis 2010 révèlent une prévalence moyenne de résistance aux benzimidazoles (BZ) de 86 %, aux
lactones macrocycliques sauf moxidectine (ML) de 52 %, au lévamisole (LEV) de 48 % et à la moxidectine
(MOX) de 21 %. Tous les genres principaux de NGI ont survécu au traitement dans diverses études. Chez les
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bovins, la prévalence de la RA variait selon les classes d’anthelminthiques de 0 à 100 % (BZ et ML), 0 à 17 % (LEV) et
0 à 73 % (MOX), et Cooperia et Ostertagia ont survécu aux traitements. Une RA suspectée chez F. hepatica a été
signalée dans 21 études portant sur 6 pays. Pour les NGI, et encore plus pour F. hepatica, il y avait un biais
d’échantillonnage en faveur des exploitations individuelles suspectées de RA, et l’effort de recherche était biaisé
vers l’Europe occidentale et en particulier le Royaume-Uni. La capture continue des résultats futurs dans la base de
données, en direct, les efforts pour éviter les biais dans le recrutement des exploitations, des tests plus précis pour
la RA et une meilleure appréciation de l’importance de la RA parmi l’industrie agricole et les décideurs politiques,
soutiendront des analyses plus sophistiquées des facteurs contribuant à la RA, et des stratégies efficaces pour
ralentir sa propagation.
Introduction
Livestock production is estimated to contribute on average
40% of agricultural production value worldwide (~60% in high
income countries, ~30% in low- and middle-income countries)
[45]. The infection of ruminant livestock with helminth para-
sites, such as gastrointestinal nematodes (GIN, primarily
trichostrongylids) and liver fluke (primarily Fasciola hepatica)
threatens the profitability and sustainability of livestock produc-
tion. Helminths affect growth [35], productivity [9] and repro-
ductive success [46], and threaten the ability of livestock
farmers to maintain high health and welfare standards.
Helminth infections are predicted to cost the European ruminant
livestock industry €1.8bn annually [9]. Furthermore, helminth
infections may increase greenhouse gas (GHG) emissions asso-
ciated with ruminant livestock production; in Scotland, liver
fluke infection is predicted to increase emissions from milk pro-
duction by ~10% [1] and GIN infection is predicted to increase
GHG emissions intensity in sheep systems by up to 30% [16,
23, 29, 47]. Therefore, effective and sustainable helminth con-
trol is essential in order to maintain high levels of productivity
and welfare, and limit the contribution of the livestock sector to
agricultural GHG emissions.
Ruminant helminth control is heavily reliant on the use of
anthelmintic products such as benzimidazoles (BZ; e.g. alben-
dazole, triclabendazole), levamisoles (LEV) and macrocyclic
lactones (ML; e.g. ivermectin, eprinomectin, moxidectin) to
maintain infections below levels that can cause clinical and
sub-clinical disease. However, Anthelmintic Resistance (AR)
in GIN has been reported worldwide in multiple nematode spe-
cies, against most anthelmintic classes and sometimes simulta-
neously multiple different classes [27, 42, 49] and there is
increasing evidence that resistance in liver fluke (F. hepatica)
may also be widespread (e.g. [3, 18, 25]). The annual cost of
AR in Europe has been estimated at €38 million and this cost
is predicted to grow because of the increasing spread of resis-
tant populations as well as occurrence of helminths resistant
to multiple anthelmintic classes [9].
Newer, more sustainable, approaches to helminth control,
which reduce the frequency of anthelmintic treatments (there-
fore, reducing selection pressure for resistance) while maintain-
ing high productivity levels are available. These approaches
include Targeted Selective Treatment (TST), based on individ-
ual animal health or production parameters [8, 34], or Targeted
Treatment (TT), based on regular seasonal factors and/or diag-
nostic measures to inform treatment decisions at group or flock
level [8]. Regional industry bodies invest significant resources
into advocating for these sustainable approaches (e.g. in
the UK, Sustainable Control of Parasites in Sheep
(https://www.scops.org.uk) and Control of Worms Sustainably
(https://www.cattleparasites.org.uk), yet farmers continue to
implement AR-selective practices, such as moving sheep to
low challenge or “clean” pastures immediately after treatment
and treating ewes and lambs more frequently than necessary
[24]. Confirmation of AR and a perceived risk of AR were
identified as having a significant positive effect on the uptake
of sustainable parasite control practices by Scottish sheep farm-
ers [24]. Similar attitudes were found in the Belgian cattle indus-
try, where a positive attitude towards anthelmintics was a barrier
to the uptake of sustainable control practices [51]. This suggests
that increasing farmer awareness of the risk associated with AR
may promote the uptake of sustainable control practices.
A systematic review of reports of AR in European ruminant
livestock confirmed that AR is spatially widespread, but also
highlighted limitations in the available data, due to sample
selection bias, a lack of georeferenced data to allow robust
spatial analyses, and a number of countries for which no
data existed [42]. In 2017, the EU COST Action COMBAR
(Combatting Anthelmintic Resistance in Ruminants; https://
www.combar-ca.eu) established a consortium of researchers
from 26 countries across Europe. The consortium aims to
advance research on the prevention of AR in helminth parasites
of ruminants and disseminate current knowledge among all
relevant stakeholders through improving diagnosis, understand-
ing the socio-economic aspects of infection and decision
making, and developing innovative, sustainable control
methods. As part of this, and to encourage the uptake of
COMBAR outputs and recommendations for sustainable
control of helminth parasites, an up-to-date synthesis of current
AR research is needed.
In this study, we draw on the collective expertise and data
held by the COMBAR consortium to address the limitations of
AR research identified previously, by collating published and
unpublished data on AR in Europe that can be used to support
advocacy for sustainable control programmes and to target
future research efforts where they are needed most.
Methods
Systematic review protocol
This review was performed and is reported according to the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) [36]: (1) preparation of a database search
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to detect potentially related articles, (2) assessment of the rele-
vancy of papers, (3) evaluation of quality, and (4) data
extraction.
Data collection and processing
A standardised spreadsheet model was populated with data
from the previous systematic review [42]. Members of the
COMBAR consortium were then invited to populate the
spreadsheet with published and unpublished data for completed
research for their respective country and surrounding countries,
if no representative was present in the consortium (e.g.
Finland). The database consequently included reports from
1980–2020. In adherence to the PRISMA guidelines, contribut-
ing authors were asked to search electronic databases (e.g.
PubMed, ISI Web of Science) and unpublished studies with
no language or date restrictions. Data requested included the
host species, region, number of farms tested, anthelmintic drug
class and active compound tested, whether AR was detected (1)
or not (0), the proportion of farms tested where AR was
detected, reference, DOI (if applicable) and publication type
(unpublished, peer-reviewed paper, Master or PhD thesis,
report, or conference abstract/proceeding). Each publication
was screened for eligibility (i.e. a study reporting the presence
or absence of AR in ruminant livestock helminths on the Euro-
pean continent), duplicates eliminated, and the eligible studies
fully reviewed. The data were then edited for consistency and
checked against the relevant publication (if applicable) by the
lead author, before being checked a second time by participat-
ing consortium members. The consortium member responsible
for the final check is recorded in the database.
Each publication or unpublished dataset, hereafter referred
to as “publication”, was given a unique identifying number.
Within each publication, multiple anthelmintic classes and live-
stock classes tested were entered as separate entries, hereafter
referred to as “studies”. Therefore, one “publication” may con-
tain several “studies”. When a publication presented separate
data for different regions within the same country, these data
were split into separate rows (studies) in the database (e.g.
[20]). When a publication presented data together for different
regions within the same country, the data were entered as a sin-
gle row (study) in the database (e.g. [17]).
For GIN, data were stratified primarily by host species and
anthelmintic class, with the exception of the ML, which were
divided into avermectins (e.g. ivermectin) and milbemycins
(i.e. moxidectin, MOX). Hereafter, MOX is analysed separately
to the other ML. Other classes were benzimidazoles (BZ),
imidazothiazoles, i.e. levamisole (LEV), amino-acetonitrile
derivatives, i.e. monepantel (MPTL), and salicylanilides, i.e.
closantel (CLOS). Studies testing more than one anthelmintic
simultaneously in the same animals were entered as combina-
tion treatments (COMB), except where the combination
involved MOX and ivermectin; in this case the anthelmintic
class was entered as MOX due to its relatively high efficacy
against some ivermectin-resistant populations of GIN, and
observations that the extent of cross-resistance is greater in iver-
mectin than MOX-resistant populations (reviewed by [39]).
For F. hepatica, data were stratified by anthelmintic com-
pound, rather than class, in order to differentiate between the
activity of triclabendazole (TBZ) and albendazole (ALB),
which have different efficacy profiles depending on the age
of the fluke [15]. Data for cattle and sheep were combined
for analyses as F. hepatica are genetically similar between host
species [4].
Inclusion criteria
Due to significant upcoming changes in protocols for
detecting AR [26], inclusion criteria were pragmatic and less
strict than in [42], and all publications investigating AR in live-
stock in Europe were eligible for inclusion. The authors’ classi-
fication of resistance was accepted in each case, regardless of
method used and level of detail provided. Although this may
result in the inclusion of publications that do not conform to
the previous guidelines on detecting AR in ruminants, it allows
the inclusion of unpublished reports (e.g. conference proceed-
ings and oral presentations), where detailed information on
the methodology (in vivo; Faecal Egg Count Reduction Test
(FECRT) and Controlled Efficacy Test (CET), in vitro, and
molecular methods) is unavailable, therefore increasing the
timeliness of the analysis and potentially reducing limitations
such as regional publication bias. Some misclassification of
resistance is consequently expected in both directions, but the
increased number of studies adds power to analysis of trends.
Data analysis
Prevalence, uncertainty and heterogeneity
Data analysis was completed in R v3.6.1 [40]. Figures were
prepared using the base R, “ggplot2” [54] and “ggpubr” [28]
packages. Tables were prepared using the sjPlot R package
[32]. Maps were prepared using the “rnaturalearth” [48],
“rgeos” [5] and “ggspatial” [13] packages.
GIN AR prevalence for each anthelmintic class and rumi-
nant species were estimated from the reported prevalences
and were weighted by sample size (number of farms in each
study) to give a weighted mean (xw), using the “weighted.
mean” function in R. Analyses were performed within each
country with data, and overall across Europe. Corresponding
sample size weighted standard deviations were estimated using
Equation (1), where x = the proportion of farms with AR,
w = weights (sample size divided by the sum of all samples):
rw ¼
X
ðw  ðx xwÞ
2
Þ:
Heterogeneity in AR prevalence estimates between studies
(aggregated by anthelmintic class and host species) was esti-
mated using the I2 statistic [21], calculated as described by
Neyeloff et al. [38], with the exception that a small value
was added to the prevalence estimates (1  107) to allow vari-
ance to be calculated as input for Cochran’s Q statistic when
estimated prevalence was zero. Negative I2 values were set to
zero [21], as well as any instances where all studies found zero
prevalence. I2 values were not estimated where only one study
existed. Higher I2 values indicate higher levels of heterogeneity.
To evaluate the impact of sample selection bias in studies
with small sample sizes (assuming that those with very small
sample sizes preferentially selected farms with suspected
AR), sample size-weighted mean prevalences, standard
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deviations and I2 were also estimated using only studies inves-
tigating 10 or more farms.
Similar analyses were not completed for F. hepatica due to
insufficient studies.
Spatial bias in research effort
Qualitative assessment of spatial bias in AR research was
made by mapping the number of publications per ruminant spe-
cies per country. Quantitative assessment of spatial bias in AR
research (GIN only) was made by relating the number of studies
per country and the research budget or cost of helminth infec-
tion per country using Spearman rank correlation (“cor.test”
function in R) and estimates for the cost of helminth infections
and research budget for projects starting after 01/01/2008 and
ending before 31/12/2017 [9].
To compare the estimated level of AR between countries
alongside the relative confidence that can be placed in that esti-
mate, an index was compiled for each, as follows:




where p is the sample-size weighted prevalence of AR (i.e.
the proportion of farms testing positive) for each active com-
pound, and na is the number of actives to which resistance
was documented to date. For GIN, prevalence for up to four
actives was included: BZ, LEV, ML, and MOX separately
from other MLs as a special case (as detailed above). MPTL
was not included in the prevalence part of the equation as it
has been tested only rarely to date, and the same applies for
the narrow-spectrum active sulphonamide, CLOS. Both, how-
ever, were added to na in countries in which cases of resis-
tance had been confirmed. Thus, for instance, a country
with reports of AR involving BZ and ML with sample-size
weighted prevalence of 0.5 and 0.1, would score
(0.5 + 0.1 + 2 = 2.6), while another reporting resistance to
BZ, LEV, ML, MOX and MPTL with prevalence, respec-
tively of 1, 0.7, 0.8, 0.4 and 0.1, would score
(1 + 0.7 + 0.8 + 0.4 + 5 = 7.9). For liver fluke, seven actives
were included in both p and na (see Results).
Confidence was not estimated from prevalence; rather, it is
an index of research effort, taking into account the depth and
breadth of investigation into the AR situation nationally:
Confidence research effortð Þ ¼
log10 Sð Þ
max log10 Sð Þð Þ
þ
log10 Fð Þ
max log10 Fð Þð Þ
þ A;
where, for each country, S is the number of separate publica-
tions (or unpublished reports) in the database, F the total
number of farms included, and A the total number of anthel-
mintic classes investigated. F is the sum of the total number
of farms used per study, regardless of how many anthelmin-
tics were assessed on each, to prevent double counting. Both
S and F were log10-transformed to stabilise variance, and
scaled to the maximum value across countries (i.e., divided
by the highest national value), to provide a measure of the rel-
ative research effort among countries in the database at the
time of the analysis. One publication from Ireland included
data from 4211 farms but used pooled faecal samples
collected by farmers: for this case, the number of farms was
divided by an arbitrary value of 10 before entry into the
equation, to avoid unfair comparison with studies using full
FECRT. The confidence index itself is arbitrary, but standard-
ised across countries, and aims to assess the relative extent to
which AR has been thoroughly investigated, to aid interpreta-
tion and prioritisation of future research.
Results of Level versus Confidence (= Research effort)
were plotted for each country: separately for GIN in either
sheep, goats or cattle, and for fluke for all host species com-
bined. Data manipulation and analysis were completed using
Excel (Microsoft, USA).
Change in anthelmintic resistance over time
Anthelmintic Resistance is a dynamic process, evolving as
helminth populations experience repeated treatment, and as
farmers change to more effective anthelmintics when treatment
failure is recognised. Research on AR is also dynamic, often
responding initially to reports of treatment failure on particular
farms, before expanding to prospective surveys, with highly
variable selection criteria, and assessing additional anthelmintic
groups as they become available or fall under suspicion of fail-
ure. Because of this, prevalence data averaged over a long per-
iod are unlikely to accurately capture the current situation in
any given country, or trends in AR over time.
To address these confounders, change in prevalence was
evaluated over time. Reports of AR on single farms were
excluded, since these are often conducted in response to sus-
pected treatment failure. Prevalence was transformed to arcsine
of the square root of prevalence in order to stabilise the variance
around values close to 0 or 1. The relationship between year
and prevalence was then tested using Pearson and Spearman
rank correlation.
In a second stage analysis, the data set was reduced to coun-
tries that reported at least three studies in different years, to fur-
ther decrease the influence of responsive investigations and to
capture change over time within countries. Sample-size
adjusted prevalence, while arguably giving the fairest indication
of how common AR is among farms in a given sample set, can
result in bias: for example, if larger surveys are conducted as
concern over resistance rises over time, more recent data will
dominate overall prevalence estimates. For this reason, preva-
lence from individual studies was averaged over each decade
without adjusting for sample size. Studies in sheep and goats
were combined to increase power, given that helminth species
are largely shared between these hosts. Italy was excluded
because its combination of low AR prevalence and high level
of reporting in recent years (19/20 reports in sheep and goats
coming after 2007) strongly affected the overall trajectory
across countries, and a single large study in the UK focusing
only on Nematodirus battus was also excluded. Initially, aver-
age prevalence was plotted for each anthelmintic group for each
decade, to visualise trends in AR over time. The database was
then searched separately for each anthelmintic group in GIN in
sheep, goats and cattle, and fluke in all hosts. For each country
meeting these criteria (including Italy), correlation between
prevalence and year was assessed as above. Where a significant
correlation was confirmed, linear regression was conducted to
evaluate the rate of change in AR prevalence over time.
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Qualitative analysis of factors influencing research
on anthelmintic resistance
The main relevant influences that might affect research on
AR were identified by SWOT (Strengths, Weaknesses, Oppor-
tunities, and Threats) analysis, to inform further AR research.
The SWOT template was drafted by the lead authors and circu-
lated for input by all co-authors.
Results
The database used in these analyses is provided as
Supplementary Material. A live version of the database is also
freely available on the Open Science Framework [43] and sub-
missions to update this website are invited via the COMBAR
website [11]. This version will be updated periodically with
additional data submitted by contributors and is made available
for reuse on a General Public license (https://www.gnu.org/
licenses/gpl-3.0.html).
Gastrointestinal nematodes
In all, 197 publications were available for analysis, repre-
senting 535 studies, 22 countries and spanning the period
1980–2020 (Fig. 1 and Fig. S1). The majority of studies inves-
tigated AR in GIN on single farms (137/535 studies; median
number of farms = 5, range = 1–550). 23.4% (n = 47) of the
“publications” were unpublished.
There was a regional research bias towards Western Europe
and especially the UK, while Eastern European countries were
relatively underrepresented in the body of AR research (Figs. 1
and 2; the four countries with the fewest publications were
located in Eastern Europe). The number of studies per country
was not correlated with the research budget reported by Charlier
et al. [9] (p = 0.49) but was positively correlated with the eco-
nomic cost of helminth infections estimated in the same study
(S = 177.95, q = 0.68, p = 0.005).
Reports of AR were widespread throughout Europe, partic-
ularly to BZ (Figs. 3 and Figs. S2–S4). AR was most widely
reported in sheep, whereas AR in cattle and goats was under-
studied in many regions, indicated by the number of countries
with no data available (Fig. S4).
Sample-size weighted prevalence estimates ranged between
0% and 100%, depending on the country and anthelmintic class
(Table 1; Fig. 3 and Figs. S2–S3). However, there was consid-
erable heterogeneity between studies (Table 1). Overall, in
sheep and goats, AR prevalence was highest against BZ,
whereas in cattle AR prevalence was highest against ML,
including MOX. Resistance was reported in sheep against all
classes of anthelmintic except derquantel-abamectin in combi-
nation, which was not tested. No resistance was reported
against MOX or MPTL in goats (only one and two studies,
respectively, tested these anthelmintics in goats). Only one
study tested MPTL in cattle, and resistance was not detected.
CLOS was not tested in goats nor cattle (Table 1). The differ-
ence between prevalence estimates using all studies and studies
with ten or more farms was negligible (Table 1), and I2 was
similar (Table 1). Therefore, unless otherwise stated, all preva-
lence estimates shown used all studies.
Information on AR in different species of GIN was limited
by variation in the extent to which species surviving treatment
were characterised, and the methods used to assess and report
this. Genera identified in post-treatment samples included
Teladorsagia, Haemonchus, Trichostrongylus, Cooperia
and Nematodirus in sheep and/or goats, and Ostertagia and
Cooperia in cattle.
Fasciola hepatica
Anthelmintic Resistance in F. hepatica was reported in 21
publications, spanning six countries (Ireland, Italy, Netherlands,
Spain, Sweden and UK). TBZ resistance was reported in the
UK, Ireland, Spain and the Netherlands. ALB resistance was
reported in Sweden and Spain. CLOS resistance was reported
in Sweden, and clorsulon resistance was reported in Spain.
No resistance was observed in Italy. The majority of publica-
tions investigated AR on individual farms, with the exception
of two larger studies. Kamaludeen et al. [25] identified TBZ
resistance in 80% of 26 farms in the UK. Holzhauer et al.
[22] identified TBZ resistance in 12% of 26 farms in the
Netherlands selected due to their high risk of AR. Most individ-
ual case reports of TBZ resistance in F. hepatica originated
from the Netherlands and were reported on 94 farms by the
Royal Animal Health Service between 1998 and 2003
(https://www.gddiergezondheid.nl).
Level of AR in relation to research effort
For GIN in sheep and goats, the observed level of treatment
failure correlated with research effort (q18 = 0.75, p = 0.001;
and q15 = 0.79, p < 0.001, respectively), but this relationship
was not apparent for studies of GIN in cattle (p = 0.46), or
Figure 1. Number of publications investigating anthelmintic resis-
tance in gastro-intestinal nematodes reported from each country and
included in the database.
6 H. Rose Vineer et al.: Parasite 2020, 27, 69
for fluke across host species (p = 0.40; Fig. 4). Across all host-
parasite combinations, countries with low levels of observed
AR also had low levels of confidence (research effort) attached
to those estimates, as a result of limited number, size and/or
breadth of studies. Only in a few countries (Germany and Italy
for GIN in sheep, and Italy for GIN in goats and cattle) was a
relatively low overall level of AR associated with relatively
robust assessment. Even in these countries, higher prevalence
of AR for some active compounds should be noted (Fig. 3
and Figs. S2–S3).
Change in reported anthelmintic resistance over
time
Prevalence of AR tended to increase over the 41 years
included in the database (Fig. 5), gradually for BZ and more
abruptly for ML (including MOX). Aggregated results in sheep
and goats since 2010 returned average prevalence of resistance
to benzimidazoles (BZ) of 86%, levamisole (LEV) 48%,
macrocyclic lactones except moxidectin (ML) 52%, and mox-
idectin (MOX) 21%. Reports of farms with GIN resistant to
LEV became more common between 1980 and 2009, but then
decreased in 2010–2020. Taking reports from sheep, goats and
cattle separately for each anthelmintic group, there was no sig-
nificant correlation between farm-level prevalence of AR and
year. In cattle, the prevalence of AR varied widely between
anthelmintic classes from 0–100% (BZ and ML), 0–17%
(LEV) and 0–73% (MOX). Only 6 of the 61 studies of cattle
GIN in the database were conducted prior to 2009, however,
and the median number of farms included was six, so the power
to track change over time was very limited. Similarly, database
entries for liver fluke comprised 34 studies from 18 sources, of
which three were prior to 2009, and the median number of
farms per study was one, precluding further exploration of
temporal trends in AR.
For GIN in sheep, six countries reported at least three studies
in different years, excluding single-farm case reports: France
(BZ), Italy (BZ, LEV, ML), the Netherlands (BZ, ML),
Slovakia (BZ) Switzerland (BZ), and the United Kingdom
(BZ, LEV, ML). No countries met this criterion for GIN in
goats or cattle, or fluke. Further analysis of these 11 country-
anthelmintic group combinations for GIN in sheep, on
arcsine-transformed prevalence and with a Bonferroni-adjusted
critical p-value of 0.0023, found significant correlations between
year and farm-level prevalence of AR for BZ in Switzerland
(rp = 0.99, p < 0.001) and in the UK for BZ (rp = 0.62,
p = 0.002) and ML (rp = 0.86, p = 0.001). Correlation in other
countries was mostly positive but not significant. Linear
regression of prevalence against year (Fig. 6; Table S4(a–c))
produced similar slopes for the rate of increase in BZ in
Figure 2. Number of publications investigating anthelmintic resistance in gastrointestinal nematodes for each ruminant host species. Green
colours represent the number of publications. Grey indicates no data. Note the different symbology ranges for each ruminant species. Variation
within countries is not shown.
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Switzerland and the UK, equating to approximately 20%
increase in prevalence per decade, and a faster rate of increase
of 33% per decade for ML.
SWOT analysis
The main relevant influences that might affect research on
AR that were identified by SWOT analysis (Strengths, Weak-
nesses, Opportunities, and Threats; Table 2) included the
strengths of existing consortia, lack of standardisation and con-
tinuity (in space and time) of data collection and surveillance,
opportunities to share data and develop coordinated approaches
in future, and potential public engagement, legislative and
practical limitations.
Discussion
In the present study, we reviewed the published and unpub-
lished literature on AR in ruminant livestock in Europe from
1980 to 2020 to strengthen the current evidence base of this
phenomenon at country and continental levels. A database of
European AR research was compiled by experts to summarise
research effort and AR status throughout Europe. The analyses
provide heuristic prevalence estimates based on the best avail-
able data, which serve as a baseline for future AR research,
guided by updated statistical guidelines [26]. This analytical
approach also helps identify research limitations and opportuni-
ties for improvement. Despite available evidence of widespread
AR in Europe, this study showed that harmonised surveys
Figure 3. Estimated prevalence of resistance against the benzimidazoles (BZ), levamisole (LEV), avermectins (ML; macrocyclic lactones),
and moxidectin (MOX) in gastrointestinal nematodes in sheep. Points and whiskers represent the weighted prevalence estimate and standard
deviation, respectively. The weighted prevalence and standard deviation across all studies are represented by the dashed black and grey vertical
lines, respectively. Note that points without whiskers represent single studies, for which standard deviations could not be estimated (i.e. they
do not represent points which the prevalence is known with a high level of confidence). Corresponding figures for goats and cattle, and for
sheep, goats and cattle using only studies with n > 9 can be found in the Supplementary Material.
8 H. Rose Vineer et al.: Parasite 2020, 27, 69
Table 1. Mean (SD in parenthesis) sample size-weighted prevalence of anthelmintic resistance stratified by anthelmintic class and host
livestock sector. BZ = benzimidazole; LEV = levamisole; ML = avermectins; MOX = moxidectin; MPTL = monepantel; CLOS = closantel; –
= no data available. I2 is provided as a measure of heterogeneity (high I2 = high heterogeneity between studies). Number of studies (number of
publications in parenthesis) indicates the number of groups tested, which may be >1 per publication. For example, some publications provide
results for multiple regions. Columns labelled “n > 9” used only studies with 10 or more farms, while columns labelled “all” used all data.
Anthelmintic Host Prevalence (all) Studies (all) I2 (all) Prevalence (n > 9) Studies (n > 9) I2 (n > 9)
BZ Sheep 0.48 (0.12) 123 (94) 0.93 0.47 (0.12) 64 (52) 0.96
Cattle 0.08 (0.04) 15 (12) 0 0.08 (0.04) 7 (6) 0.33
Goats 0.51 (0.17) 31 (29) 0.86 0.52 (0.16) 12 (11) 0.94
LEV Sheep 0.32 (0.06) 43 (40) 0.88 0.31 (0.05) 19 (18) 0.94
Cattle 0.12 (0.01) 4 (4) 0 0.18 (0) 1 (1) –
Goats 0.2 (0.04) 11 (11) 0.68 0.21 (0.03) 4 (4) 0.54
ML Sheep 0.29 (0.07) 83 (61) 0.79 0.29 (0.06) 30 (28) 0.91
Cattle 0.32 (0.1) 31 (24) 0.78 0.25 (0.08) 10 (9) 0.89
Goats 0.44 (0.18) 27 (24) 0.79 0.43 (0.18) 7 (7) 0.94
MOX Sheep 0.17 (0.03) 36 (35) 0.68 0.17 (0.03) 13 (13) 0.87
Cattle 0.27 (0.1) 9 (6) 0.50 0.23 (0.09) 4 (3) 0.70
Goats 0.01 (0.01) 7 (7) 0 0 (0) 1 (1) –
MPTL Sheep 0.05 (0.03) 10 (10) 0 0.02 (0) 3 (3) 0
Cattle 0 (0) 1 (1) – – 0 (0) –
Goats 0 (0) 2 (2) 0 0 (0) 1 (1) –
CLOS Sheep 0.25 (0) 2 (2) 0.75 0.27 (0) 1 (1) –
Cattle – 0 (0) – – 0 (0) –
Goats – 0 (0) – – 0 (0) –
Figure 4. Level of anthelmintic resistance in each country, using a composite index across all drugs tested, in relation to research effort (=
confidence) as a function of number of studies, farms and anthelmintics investigated. See methods for details of indices. Note that horizontal
scales are different for each panel. For gastrointestinal nematodes in sheep in Ireland, the confidence score was modified to take account of a
single large study that assessed treatment efficacy through pooled faecal sampling by farmers at and after treatment [54]. GIN = Gastrointestinal
nematodes. Country abbreviations: AT = Austria, BE = Belgium, CH = Switzerland, CZ = Czechia, DE = Germany, DK = Denmark,
EL = Greece, ES = Spain, FR = France, IE = Ireland, IT = Italy, LT = Lithuania, NL = Netherlands, NO = Norway, PL = Poland,
RO = Romania, RS = Serbia, SE = Sweden, SK = Slovakia, UK = United Kingdom.
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estimating its extent are scarce, lack standardisation, and are
spatially biased at a country level. However, as the knowledge
base on the AR status in livestock in Europe improves, this will
be a stimulus for studies in additional countries, and for using
more rigorous sampling strategies.
Current status of anthelmintic resistance in
Europe and reporting bias
Anthelmintic resistance in GIN was reported throughout
Europe and was detected wherever studies were conducted (with
some notable exceptions, e.g. Italy). Prevalence of AR in GIN
against BZ, LEV, ML and MOX ranged between 0% and
48% when averaged over the entire database, but confidence
intervals were wide and there was a high level of heterogeneity
between studies. There was also considerable variation within
and between regions depending on host species and anthelmintic
class. Ten studies were largely in agreement that AR against
MPTL in sheep is currently rare in Europe, although these stud-
ies were focussed on only six countries. AR in F. hepatica was
reported in only five countries, and there were insufficient data
to draw conclusions on AR in GIN against CLOS.
Although consultation with regional experts to compile
unpublished datasets (almost a quarter of all publications),
and implementing looser inclusion criteria, allowed the inclu-
sion of data from more countries than in previous reviews
[42], publications were still biased towards Western European
countries. This appeared to be somewhat needs-led and justified
by the estimated economic impact of helminth infections in
these countries [9]. Nevertheless, spatial sampling bias, e.g.
due to research expenditure, convenience sampling (e.g. close
to research institutions or close to highways) or cultural differ-
ences (e.g. regional variability in response rates), can limit the
analysis and interpretation of AR data. Furthermore, with some
notable exceptions (e.g. studies of AR in cattle in Italy), there
was a bias towards publishing positive findings: this is evident
in the fact that the spatial country-level distribution of AR in
Europe (Fig. S4) is reflected in the spatial distribution of publi-
cations per country (Fig. 2). Failing to account for these biases
could result in incorrect or misleading inferences [7]. As a
result, the current data are insufficient to conduct advanced
geostatistical analyses.
Research effort and priorities for future
investment
The relationship between research effort and observed AR
was investigated semi-quantitatively using composite indices
of level of AR across anthelmintic groups and research effort
or confidence, per country. Level of AR included the number
of anthelmintic groups to which AR was reported and observed
prevalence of resistance to each (i.e. proportion of farms with
AR). Research effort, indicative of relative confidence in the
levels of AR, comprised the number of studies in the database,
the total number of farms investigated, and the number of
anthelmintic groups tested. The positive relationship between
level of AR and research effort in the better-studied systems
(especially GIN in sheep) is to be expected for two main rea-
sons. Firstly, as more studies are conducted and more anthel-
mintic groups tested, the chance of finding AR increases.
Secondly, a perceived problem with anthelmintic efficacy is
often the stimulus for investigations, and finding AR will pro-
vide justification for further and larger studies, fuelling a cycle
of perceived and observed AR. To some extent, therefore, dif-
ferences between countries in both observed level of treatment
failure and research effort represent different positions on a tra-
jectory of learning about existing AR problems, as well as
between-country heterogeneity in true levels of AR. Neverthe-
less, the fact that low research effort is invariably associated
with low apparent levels of treatment failure should stimulate
Figure 5. Average farm-level prevalence of anthelmintic resistance
in gastrointestinal nematodes in sheep and goats, by decade. The
arithmetic mean was taken of all reports including more than one
farm, from countries with a minimum of three reports in different
years, excluding Italy (see text). BZ = benzimidazoles, n = 64;
LEV = levamisole, n = 14; ML = macrocyclic lactones excluding
moxidectin, n = 23; MOX = moxidectin, n = 10. Error bars are
standard deviations.
Figure 6. Change in the prevalence of anthelmintic resistance
(= proportion of farms testing positive) for benzimidazoles (BZ) in
Switzerland (CH; dotted black line) and the United Kingdom (UK;
dashed red line), and macrocyclic lactones excluding moxidectin
(MOX) in the United Kingdom (solid blue line). Only studies testing
more than one farm were included. For regression equations, see
Table S4(a–c). Data point for CH-BZ at (2016, 1) is partly concealed.
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further studies, especially in those countries positioned towards
the lower left in Figure 4.
Overall confidence in AR status in GIN in cattle, and in
fluke in both sheep and cattle, was very low, and further studies
should also be prioritised to address these knowledge gaps in all
countries. In sheep and goats, high confidence can be placed in
high levels of AR in several countries (upper right regions in
Fig. 4). The aim of further studies in these countries should
be not so much to demonstrate a problem with anthelmintic
efficacy, as to focus on solutions for farms facing resistance
to multiple anthelmintic groups, including how newer groups
(such as the aminoacetonitrile derivatives and spiroindole
anthelmintics) should be used strategically, alongside the exist-
ing anthelmintic classes, to maintain the active life of both for
as long as possible and allow for implementation of alternative
approaches. Elsewhere, more reliable estimates of the preva-
lence of AR would be beneficial.
Increase in prevalence of resistance across
anthelmintic groups
Robust temporal analyses were hindered by small sample
sizes (number of studies) and limited time range, as well as
potential bias in farm selection. However, with the notable
exception of LEV, for which some surveys gave inaccurate
results before the mid-90s [19], successive studies following
initial reports of AR invariably prove its existence, rather than
identify such reports as exceptions to the overall situation, and
this tendency suggests increasing AR over time. A trend of
gradually increasing BZ resistance was evident both in aggre-
gate (Fig. 5) and within more data-rich countries (Fig. 6).
The later introduction of ML, especially MOX, and conse-
quently more recent reports of AR in these groups make tempo-
ral analyses difficult, but a trend of increasing prevalence is also
evident, at a faster rate than for BZ. This confirms a tendency
towards shortening time lags between introduction of new
anthelmintics to the market and appearance of resistance to
them [26], which might indicate shared mechanisms of AR
between some anthelmintic groups, differences in the nature
of inheritance of resistance genes (e.g. dominant or recessive)
or differences in initial abundance of resistance genes within
the populations at release of product. Alongside research efforts
to identify the scale of the problem, therefore, alternative strate-
gies for sustainable parasite management, including targeted
anthelmintic use, are essential and require significant new
research [10, 37, 52].
Increasing AR is less obvious after 2009 for LEV, although
sample sizes are low and there is no robust evidence of a
decrease in prevalence. Studies in New Zealand have suggested
that a change to less intensive treatment regimens might be suc-
cessful in slowing or even reversing anthelmintic resistance in
GIN populations [31]. The relatively low reported prevalence
of AR in Italy despite high research effort also indicates that
maintenance of anthelmintic efficacy is possible, and potentially
attributable to aspects of farm management such as restraint in
treatment of lactating ewes [41], although reports are biased to
the south of the country where such factors pertain. Neverthe-
less, in countries for which longitudinal data were available,
there was a clear trend towards increasing prevalence of AR.
Average prevalence over the entire period studied, as shown
in Figure 3, is therefore likely to underestimate the current scale
of the problem. For example, in the UK the prevalence of resis-
tance to BZ in sheep is reported as close to 50% over the whole
period, but 82% in studies since 2010. Current high levels of
resistance can therefore be concealed by a longer history of
investigations while AR was less common. Conversely, high
apparent prevalence could be generated by a few recent reports,
which focus on farms where problems are suspected: thus, for
BZ in sheep, AR prevalence of 100% in Poland and Romania
results from a small number of single-farm studies.
The analyses of AR revealed several sources of bias, which
can confound interpretation and impede solutions-oriented
research. Thus, bias makes it very difficult to identify risk
factors for rapid development of AR, and to determine whether
Table 2. SWOT analysis for AR research in Europe. COMBAR = EU COST Action Combating Anthelmintic Resistance in Europe [37];
AR = Anthelmintic Resistance; STAR-IDAZ IRC = International Research Consortium on Animal Health.
Internal External
Strengths Weaknesses Opportunities Threats
European initiative endorsed by
all COMBAR members




Real-time data sharing including
a live database on AR in
ruminant livestock
Insufficient public awareness of
AR (compared to
antimicrobial resistance)
Consistency and compliance with
the priorities of the STAR-
IDAZ IRC on animal health
Lack of harmonised tests for field
and laboratory detection of AR




The pattern in the AR maps
could be misleading (black-
box effect)
Disseminate knowledge and
promote the use of
standardised methods for
determining AR





and data biased towards
Northern European countries
and towards GIN
Striving to obtain precise
location of AR cases
Data protection legislation may
hamper the availability of
georeferenced data to allow
robust spatial analyses of AR
Operate in real time, providing
maps, tables and reports
Spatial sampling bias can limit
the analysis and interpretation
of AR data
Rapid, responsive, efficient, and
cost-effective planning of AR
surveys
Confounding factors not related
to AR may not be taken into
consideration
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differences in observed levels of treatment failure between
countries, and between farms, can be used to guide future
strategies. While removal of bias in studies of AR is difficult
and perhaps impossible, greater efforts to reduce or account
for it could support more refined analyses and better under-
standing of regional patterns and risk factors on which to base
advice to farmers and policy makers.
SWOT analysis
SWOT analysis also identified potential biases, and within-
country variation that could affect current and future AR
research. Although data protection legislation (especially EU
Regulation 2016/679: General Data Protection Regulation;
applicable from 2018) may limit the resolution of location data
that can be published, there is now an opportunity to improve
reporting of AR research to facilitate future geostatistical anal-
yses. Future studies should strive to publish the location of
farms in a way that protects farmer anonymity e.g. publishing
latitudes and longitudes to one decimal place would give an
indicative spatial accuracy of ±10 km at the equator.
During past decades, European research and investment
tended to focus on resistance to antibiotics, but AR research
effort accelerated after the turn of the millennium, coinciding
with investment by the European Commission in several AR
research consortia: PARASOL (€3.9M; https://cordis.europa.
eu/project/id/22851) GLOWORM (€3M; https://cordis.europa.
eu/project/id/288975/reporting), DELIVER (€3.6M; https://
cordis.europa.eu/project/id/23025) and PARAGONE (€9M;
https://cordis.europa.eu/project/id/635408). As a result, AR is
now considered part of the broader antimicrobial resistance
problem and stakeholders have recently recognised the emerg-
ing risk and agreed that it is now time to take concrete actions
to ensure the responsible use of all veterinary medicines, includ-
ing anthelmintics in livestock species [14].
The need for standard methods for resistance
detection and study design
Novel and harmonised protocols for the detection of AR in
ruminants to include improved statistics and modified parasite
enumeration methods that reduce measurement error [26, 53]
are likely to improve the accuracy of AR diagnosis in future.
This presents an opportunity for parallel attempts to reduce
sampling error by introducing more robust randomised sam-
pling protocols (e.g. [33]) and larger sample sizes. Greater accu-
racy in measuring AR would allow regional prevalence
estimates to be refined and more advanced meta-analyses to
be conducted to disentangle heterogeneity between studies aris-
ing from measurement error, sampling error, and true regional
differences. The inclusion criteria for the current analysis were
intentionally broad and a high level of trust was placed in the
authors’ classification of resistance, especially where method-
ological detail was limited (e.g. in unpublished abstracts and
reports); future studies would benefit from standardised and
scalable methods for classification of AR, especially in liver
fluke. Improved technologies for species identification, such
as nemabiome [2] could also underpin more species-specific
information on AR among GIN, and attenuate bias in AR esti-
mates on mixed GIN populations.
Confidence in AR estimates is limited by the number of
studies undertaken in each country, the number of farms
included in each, and study design. The way in which farms
were selected is also important. Preferential and opportunistic
sampling is common in veterinary parasitology [6, 7], particu-
larly where a phenotype or genotype is rare. Therefore, bias
is to be expected, at least in the early stages of resistance to
any active compound, as research effort will often focus on
investigating farms reporting reduced efficacy of anthelmintics.
Although fit for the original purpose of the study, this intro-
duces difficulties for additional analysis and interpretation of
findings, and comparison of results between regions. AR
research generally lacks studies with large samples of randomly
selected farms: the studies collated here most often sampled sin-
gle farms close to universities or research institutes, and the
median sample size for AR studies on GIN was only five farms.
Even for larger, later studies that attempt to gain more compre-
hensive information, it is often impossible or impractical to
select farms truly randomly, as logistics and farmer compliance
are important limitations.
Non-random sampling, for example, due to researchers
selecting farms with suspected AR, or farmers self-selecting
to participate (possibly because they suspect they have AR on
their farm) may inflate estimated prevalence. This is supported
by a survey of both randomly selected and non-randomly
selected sheep flocks in Norway [12] where the prevalence of
BZ resistance in GIN on randomly selected farms in Rogaland
(29%, n = 6) was lower than on non-randomly selected farms
(80%, n = 10). Similarly, small sample sizes (e.g. due to
resource limitations, since AR detection methods are time con-
suming for researchers and farmers) may inflate uncertainty.
Study design includes the active compounds to be tested and
whether or not to include an untreated control group, which
are also subject to farmer consent: FECRT with all five licensed
groups for sheep (including an avermectin and moxidectin) and
a control group, with 15 animals in each, would require 105
animals, which is often unrealistic on commercial farms due
to the time and cost of sampling; consequently, most studies
test only a limited range of anthelmintics. The conditions for
inclusion of animals in the test, such as pre-treatment Faecal
Egg Count (FEC) varies between studies, as does the detection
limit of the FEC method used, and the extent of species identi-
fication. The gold standard for assessing AR, the CET, requires
slaughter of both control animals and treated animals, and is not
suitable for monitoring on commercial farms. Each FECRT or
in vitro method is open to error, e.g. FECs are an indirect mea-
sure of anthelmintic efficacy against adult helminths. Sample
size within the existing database was not sufficiently high to
compare AR prevalence across countries while taking account
of variation in method and would be further undermined by
concealed variation and bias.
Slowing the future development of anthelmintic
resistance
Frequent anthelmintic treatment is held as one of the major
reasons for the genesis of resistant GIN populations, and a
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number of approaches are advocated to slow the development
of AR [26]. Extensive research has been performed to establish
strategies for targeted (group) and targeted selective treatments
(single animal treatment), aiming at a reduction of the overall
treatment frequency and amount of anthelmintic administered
[8, 26]. There is a pressing need for improved, rapid diagnostics
to facilitate routine monitoring and targeted treatment strategies.
Nevertheless, two successful examples of monitoring pro-
grammes based on these strategies are reported from Switzer-
land and Italy. Experiences from monitoring programmes are
well suited for dissemination to further countries.
In Switzerland, a programme was established in 1999 by
the Small Ruminant Health Service to provide an annual service
for sheep and goat farmers based on quantitative faecal exam-
ination. The programme, now including about 1400 farms, is
partially subsidized by the government, covering about one
third of the costs. Pooled samples are analysed from different
groups of animals and, based on the results, veterinary advice
is given with respect to anthelmintic treatment and further
sampling. An evaluation performed five years after establish-
ment of the program revealed that, on 73% of the farms, GIN
were controlled successfully, with a mean annual treatment fre-
quency of 2.0 compared with 3.4 on farms that did not partic-
ipate in the programme. Participation in faecal monitoring also
strengthened collaboration with the veterinarian – according to
the farmers, the support of the veterinarian was “good” or “very
good” in 86% of cases (unpublished data).
In Italy, the Regional Centre for Monitoring Parasitic Infec-
tions (Centro Regionale per il Monitoraggio delle Parassitosi –
CREMOPAR) has been established since 2000 by the Depart-
ment of Agriculture and Livestock Production of the Campania
region and is economically supported by the farmers’ associa-
tions of Campania and other Italian regions. The strategies
for the management of livestock infections caused by GIN, liver
flukes and other parasites are based on promoting: best practice
for diagnosis, regular monitoring on-farm (at least three FEC
per year), best practice for treatment, monitoring the efficacy
of treatments through the FECRT, and tailored advice to farm
veterinarians on sustainable parasite control. These recommen-
dations and activities are now well integrated into routine farm
management of large ruminants (cattle and water buffaloes) and
small ruminants (sheep and goats). The programme includes
over 1000 farms per year. A survey performed for the last dec-
ade revealed that, on 88% of the farms, GIN were controlled
successfully, with a lower mean annual treatment frequency
of 2.0 compared with 3.1 on farms that did not participate in
the programme. Participation in faecal monitoring also strength-
ened collaboration with the veterinarian – according to the
farmers the support of veterinarian was “very good” in 94%
of cases.
Recent studies suggest that improving awareness of hel-
minth control and AR may improve the uptake of sustainable
parasite control practices [50]. Jack et al. [24] found that farm-
ers’ perceptions of AR risk (perceiving AR as being a problem
in their region and a threat to their farming business) positively
affected uptake of sustainable parasite control practices on
Scottish sheep farms. In cattle farmers, Vande Velde et al.
[51] found that a positive attitude towards anthelmintics was
a barrier to the uptake of sustainable parasite control practices
and that risk perception of anthelmintic resistance had no effect
on the adoption intention of diagnostic methods, indicating that
farmers did not yet consider AR a problem. Therefore, provid-
ing farmers and prescribers with access to information on the
potential risk of AR in their region, such as the data presented
here, may improve the uptake of sustainable control practices.
This is supported by a similar social science veterinary epidemi-
ology study of UK horse owners, which suggested that increas-
ing perceived knowledge of helminth control and AR could
improve the uptake of sustainable control practices [44]. Given
between and within-country differences in livestock manage-
ment and in cultural norms, research to understand uptake of
sustainable control practices in individual European countries
would be of benefit.
Conclusions
AR is present across the European continent and despite the
limitations of the current body of AR research, the analyses pre-
sented here provide useful indicators of the potential scale and
potential future trajectory of the problem of AR in Europe, and
may help improve the uptake of sustainable control practices.
As the presence of AR in GIN is now widespread globally,
and reports of AR in F. hepatica are increasing, confirming
AR presence on small numbers of farms may no longer be nec-
essary. The introduction of more rigorous methods for detecting
AR is an opportunity to shift focus to employing robust ran-
domised sampling methods that would allow more detailed epi-
demiological investigations, including improved estimates of
regional prevalence and risk factor analysis.
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